Arcturus Therapeutics is developing a portfolio of mRNA therapeutics for treatment of diseases with unmet medical needs. Our hope and vision are to build transformative, life-changing medicines for patients and their families.
Our team has extensive experience in the discovery and development of mRNA medicines, as well as design and utilization of lipid-mediated drug delivery systems. This combination of in-house expertise, innovative spirit, and passion for what we do, uniquely position us to catalyze the next generation of mRNA medicines.
July 1, 2020
Arcturus Therapeutics Announces the Formation of its Vaccine Platform Scientific Advisory Board
June 29, 2020
Arcturus Therapeutics to be Added to Russell 2000® Index
June 11, 2020
Arcturus Therapeutics to Present at the Raymond James Human Health Innovation Virtual Conference